{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:17:48Z","timestamp":1792804668979,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013248","name":"Family Process Institute","doi-asserted-by":"publisher","award":["BES-2012-053726"],"award-info":[{"award-number":["BES-2012-053726"]}],"id":[{"id":"10.13039\/100013248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013248","name":"Family Process Institute","doi-asserted-by":"publisher","award":["BES-2015-071612"],"award-info":[{"award-number":["BES-2015-071612"]}],"id":[{"id":"10.13039\/100013248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014540","name":"Xarxa de Bancs de Tumors de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR17\/861"],"award-info":[{"award-number":["SGR17\/861"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["IIS10\/00014"],"award-info":[{"award-number":["IIS10\/00014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ebiom.2020.102786","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T17:34:10Z","timestamp":1590341650000},"page":"102786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses"],"prefix":"10.1016","volume":"56","author":[{"given":"Giulia","family":"Raimondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mato-Berciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pascual-Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rovira-Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cuatrecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantino","family":"Fondevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"S\u00e1nchez-Cab\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Begthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia F.","family":"Boj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Clevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102786_bib0001","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ebiom.2020.102786_bib0002","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ebiom.2020.102786_bib0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2020.102786_bib0004","article-title":"Model organoids provide new research opportunities for ductal pancreatic cancer","volume":"3","author":"Boj","year":"2016","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.ebiom.2020.102786_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102786_bib0006","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science (80-)"},{"key":"10.1016\/j.ebiom.2020.102786_bib0007","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s12885-017-3604-y","article-title":"A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: parvOryx02 protocol","volume":"17","author":"Hajda","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2020.102786_bib0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers10040103","article-title":"Role of Gene Therapy in Pancreatic Cancer\u2014A Review","volume":"10","author":"Sato-Dahlman","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ebiom.2020.102786_bib0009","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/cancers10100356","article-title":"The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers","volume":"10","author":"Eissa","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ebiom.2020.102786_bib0010","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell\u2013 and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102786_bib0011","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2020.102786_bib0012","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/nprot.2016.097","article-title":"Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation","volume":"11","author":"Broutier","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2020.102786_bib0013","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1099\/vir.0.81889-0","article-title":"Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting","volume":"87","author":"Bayo-Puxan","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2020.102786_bib0014","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2010.173","article-title":"Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses","volume":"18","author":"Rojas","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2020.102786_bib0015","doi-asserted-by":"crossref","first-page":"22700","DOI":"10.18632\/oncotarget.15169","article-title":"A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel","volume":"8","author":"Mato-Berciano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2020.102786_bib0016","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ymthe.2018.09.016","article-title":"Bioselection reveals miR-99b and miR-485 as enhancers of adenoviral oncolysis in pancreatic cancer","volume":"27","author":"Rovira-Rigau","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2020.102786_bib0017","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1038\/cddis.2014.183","article-title":"Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy","volume":"5","author":"Grabinger","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ebiom.2020.102786_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2011.11.004","article-title":"Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models","volume":"317","author":"Jose","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2020.102786_bib0019","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/nprot.2009.171","article-title":"Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice","volume":"4","author":"Kim","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2020.102786_bib0020","doi-asserted-by":"crossref","first-page":"e93608","DOI":"10.1371\/journal.pone.0093608","article-title":"Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2020.102786_bib0021","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","article-title":"Comprehensive analysis of normal adjacent to tumor transcriptomes","volume":"8","author":"Aran","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2020.102786_bib0022","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-015-0413-2","article-title":"AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-kappaB mediated uPAR activation","volume":"14","author":"Maliandi M","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2020.102786_bib0023","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1743-422X-7-148","article-title":"Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells","volume":"7","author":"Lyle","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.ebiom.2020.102786_bib0024","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1525-0016(03)00182-5","article-title":"Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism","volume":"8","author":"Martin","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2020.102786_bib0025","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102786_bib0026","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1158\/2159-8290.CD-17-0268","article-title":"A road map for precision cancer medicine using personalized models","volume":"7","author":"Picco","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2020.102786_bib0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12885-018-4453-z","article-title":"A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer","volume":"18","author":"Hirooka","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2020.102786_bib0028","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic virotherapy promotes intratumoral T cell infiltration and improves Anti-PD-1 Immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102786_bib0029","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2020.102786_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/CMR.0000000000000399","article-title":"Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB\u2013IVM1c melanoma","volume":"28","author":"Chesney","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ebiom.2020.102786_bib0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/OV.S165479","article-title":"Three-dimensional tumor cell cultures employed in virotherapy research","volume":"7","author":"Kloker","year":"2018","journal-title":"Oncolytic Virother"},{"key":"10.1016\/j.ebiom.2020.102786_bib0032","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s12276-018-0115-0","article-title":"Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice","volume":"50","author":"Choi","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ebiom.2020.102786_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102786_bib0034","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2020.102786_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2020.102786_bib0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/cgt.2016.67","article-title":"OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro","volume":"24","author":"Yano","year":"2017","journal-title":"Cancer Gene Ther"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:53Z","timestamp":1762455713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420301614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"alternative-id":["S2352396420301614"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102786","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102786"}}